Tevogen Bio Holdings Inc.
TVGN
$0.9922
-$0.0178-1.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.44M | -5.88M | -9.66M | 11.26M | -3.63M |
| Total Depreciation and Amortization | 103.50K | 101.70K | 100.00K | 98.30K | 100.90K |
| Total Amortization of Deferred Charges | -800.00K | 0.00 | 0.00 | 800.00K | -- |
| Total Other Non-Cash Items | 7.84M | 3.13M | 5.21M | -14.84M | 1.62M |
| Change in Net Operating Assets | -749.00K | -1.15M | 1.37M | 517.80K | -68.10K |
| Cash from Operations | -3.05M | -3.80M | -2.98M | -2.16M | -1.98M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | 0.00 | 1.00M | -- | -- | 350.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 2.00M | 4.00M | 2.80M | 2.20M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 229.30K | 72.30K |
| Cash from Financing | 2.00M | 5.00M | 2.80M | 2.43M | 422.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.05M | 1.20M | -182.50K | 265.50K | -1.55M |